MD3341F1 - Method of treatment of organic lesions of the central nervous system in infants - Google Patents
Method of treatment of organic lesions of the central nervous system in infants Download PDFInfo
- Publication number
- MD3341F1 MD3341F1 MDA20060252A MD20060252A MD3341F1 MD 3341 F1 MD3341 F1 MD 3341F1 MD A20060252 A MDA20060252 A MD A20060252A MD 20060252 A MD20060252 A MD 20060252A MD 3341 F1 MD3341 F1 MD 3341F1
- Authority
- MD
- Moldova
- Prior art keywords
- treatment
- intramuscular
- series
- injections
- week
- Prior art date
Links
- 238000011282 treatment Methods 0.000 title abstract 7
- 210000003169 central nervous system Anatomy 0.000 title abstract 2
- 230000003902 lesion Effects 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 238000007918 intramuscular administration Methods 0.000 abstract 5
- 239000007924 injection Substances 0.000 abstract 4
- 238000002347 injection Methods 0.000 abstract 4
- 210000000988 bone and bone Anatomy 0.000 abstract 1
- 210000004720 cerebrum Anatomy 0.000 abstract 1
- 239000005515 coenzyme Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 208000014674 injury Diseases 0.000 abstract 1
- 239000006187 pill Substances 0.000 abstract 1
- 210000002826 placenta Anatomy 0.000 abstract 1
- 239000000829 suppository Substances 0.000 abstract 1
- 230000008733 trauma Effects 0.000 abstract 1
- 230000003442 weekly effect Effects 0.000 abstract 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Inventia se refera la medicina, neurologie, pediatrie si este destinata tratamentului leziunilor organice ale sistemului nervos central la sugari. Metoda, conform inventiei, consta in aceea ca pacientului i se administreaza Cerebrum Compositum intramuscular cate 0,6…1,1 ml de 2 ori pe saptamana in decurs de 5…10 saptamani, Limphomyosot per os cate2…3 picaturi de 3 ori pe zi timp de 3 luni, Spascupreeli cate 1 supozitor pe noapte timp de 10…20 zile, Nevroheeli cate 1/4 pastila de 3 ori pe zi timp de 2…3 luni, Traumeli C intramuscular cate 0,6…1,1 ml de 2 ori pe saptamana, la o serie de tratament 5…10 injectii, Coenzyme Compositum intramuscular cate 0,5…1,0 ml o data pe saptamana, la o serie de tratament 3…5 injectii, Ubichinoni Compositum intramuscular cate 0,5…1,0 ml o data pe saptamana, la o serie de tratament 3…5 injectii, Placenta Compositum intramuscular cate 0,5…1,0 ml o data pesaptamana, la o serie de tratament 3…5 injectii. Seria de tratament se repeta de 2…3 ori peste 2…4luni.The invention relates to medicine, neurology, pediatrics and is intended for the treatment of organic lesions of the central nervous system in infants. The method, according to the invention, is that the patient is given intramuscular Cerebrum Compositum 0.6… 1.1 ml 2 times a week within 5… 10 weeks, Limphomyosot per bone 2… 3 drops 3 times a day for 3 months, Spascupreeli each 1 suppository per night for 10… 20 days, Neurohephalosis 1/4 pill 3 times a day for 2… 3 months, Intramuscular C trauma 0.6… 1.1 ml of 2 or weekly, at a series of treatments 5… 10 injections, Coenzyme Intramuscular Compositum each 0.5… 1.0 ml once a week, at a series of treatment 3… 5 injections, Ubichinoni Intramuscular Compositum each 0.5… 1 , 0 ml once a week, at a series of treatments 3 ... 5 injections, Placenta Intramuscular Compositum each 0.5 ... 1.0 ml once a week, at a series of treatment 3 ... 5 injections. The treatment series is repeated 2 ... 3 times over 2 ... 4 months.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDA20060252A MD3341G2 (en) | 2006-10-27 | 2006-10-27 | Method of treating the organic central nervous system lesions to infants |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDA20060252A MD3341G2 (en) | 2006-10-27 | 2006-10-27 | Method of treating the organic central nervous system lesions to infants |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MD3341F1 true MD3341F1 (en) | 2007-06-30 |
| MD3341G2 MD3341G2 (en) | 2008-01-31 |
Family
ID=38229408
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MDA20060252A MD3341G2 (en) | 2006-10-27 | 2006-10-27 | Method of treating the organic central nervous system lesions to infants |
Country Status (1)
| Country | Link |
|---|---|
| MD (1) | MD3341G2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MD966Z (en) * | 2015-01-29 | 2016-06-30 | Штефан ГАЦКАН | Method for predicting the risk of development of congenital pathology of the central nervous system in the fetus |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU1286206A1 (en) * | 1984-07-18 | 1987-01-30 | Ташкентский государственный медицинский институт | Method of treatment of perinatal encelophalopathy |
-
2006
- 2006-10-27 MD MDA20060252A patent/MD3341G2/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| MD3341G2 (en) | 2008-01-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NI201100147A (en) | METHODS TO TREAT ACUTE MYOCARDIAL INFARCTIONS AND RELATED DISORDERS. | |
| BR112012009376A2 (en) | pharmaceutical composition, pharmaceutical dosage form, process for its preparation, methods of treatment and its use | |
| SI2903616T1 (en) | Verwendung von masitinib in kombination mit gemcitabin zur behandlung von einer untergruppe der patienten mit bauchspeicheldrusenkrebs | |
| BR112014018485A8 (en) | USE OF LAQUINIMOD TO TREAT PATIENTS WITH CROHN'S DISEASE WHO HAVE FAILED FIRST LINE ANTI-TNF THERAPY | |
| MX2017006938A (en) | Combination therapy for treatment of cancer. | |
| Frutuoso et al. | Medication-related osteonecrosis of the jaw: a systematic review of case reports and case series | |
| Naveau et al. | Osteonecrosis of the jaw in patients taking bisphosphonates | |
| Zhang et al. | Fucoidan inhibits tooth movement by promoting restorative macrophage polarization through the STAT3 pathway | |
| BR112015012497A2 (en) | pharmaceutical combinations | |
| MD3341F1 (en) | Method of treatment of organic lesions of the central nervous system in infants | |
| BR112023011605A2 (en) | USE OF PEPTIDE, METHOD OF TREATMENT OF CANCER OR VIRAL INFECTIONS, AND PHARMACEUTICAL COMBINATION | |
| PE20061051A1 (en) | PHARMACEUTICAL COMPOSITION INCLUDING MIRTAZAPINE S | |
| BRPI0800744A2 (en) | Salmonella Infection Inhibition Composition for Chick and Salmonella Infection Inhibition Method in Chicks | |
| MD3803F1 (en) | Method of treating hyperkinesia of children | |
| MD3185F1 (en) | Method of chronic tonsillitis treatment to children | |
| DK2037949T3 (en) | Process for preparing a "transfer factor" drug | |
| MD2827G2 (en) | method of prophylaxis of the dishormonal mammary hyperplasiae | |
| Brance et al. | Glucocorticoid-induced osteoporosis: Analysis of the international guidelines for prevention and treatment | |
| DE602006018619D1 (en) | COMPOSITIONS FOR THE TREATMENT OF LUMINOUS INFLAMMATORY DISEASES | |
| MD3446G2 (en) | Method of HIV infection treatment | |
| MD3424G2 (en) | Method of treating the essential hypertension associated with marked anxious states and neuroses | |
| Singh et al. | Osteonecrosis of the maxilla in a patient on ibandronate: A case report | |
| ATE526984T1 (en) | BONE MORPHOGENETIC PROTEINS FOR USE IN THE TREATMENT AND PREVENTION OF NEUROBLASTOMAS | |
| SG10201900731UA (en) | “SILVER SECRET SPELLS” (SSS), a “SPELLS or ENERGY for HEALING & HEALTH” on “BUDDHIST HEALING WAVES” that will 100% fully “Healed & Cured” the patient whom suffering from “Cancer, HIV, Disease” (Known as a disorder of structure or function in a Human, Animal, Plant and Unknown)• Healing without “MEDICATION”• Healing without “CHEMOTHERAPY”• Healing without “RADIOTHERAPY” | |
| RU2007145693A (en) | METHOD FOR MAINTAINING LITTLE QUALKS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG4A | Patent for invention issued | ||
| KA4A | Patent for invention lapsed due to non-payment of fees (with right of restoration) | ||
| MM4A | Patent for invention definitely lapsed due to non-payment of fees |